Online citations, reference lists, and bibliographies.

ENETS Consensus Guidelines For The Management Of Bone And Lung Metastases From Neuroendocrine Tumors

Beata Kos-Kudła, Dermot O’Toole, Massimo Falconi, David Gross, Günther Klöppel, Anders Sundin, John Ramage, Kjell Öberg, Bertram Wiedenmann, Paul Komminoth, Eric van Custem, Mohandes Mallath, Mauro Papotti, Martyn Caplin
Published 2010 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors
This paper references
The use of radioisotopes for palliation of metastatic bone pain.
Ioannis Gkialas (2008)
10.1159/000098009
Gastrinoma (Duodenal and Pancreatic)
Robert T. Jensen (2006)
roendocrine tumor epidemiology : contrasting Norway and North America
S Hadi (2008)
10.1097/00006231-200208000-00006
Evaluation of 111In-pentetreotide, 131I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease
Johanna Maria Zuetenhorst (2002)
10.1053/j.gastro.2007.01.006
Survival from malignant digestive endocrine tumors in England and Wales: a population-based study.
Côme Lepage (2007)
10.1016/0002-9343(85)90313-4
The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease.
E M Ross (1985)
10.1517/14728214.12.2.253
Emerging therapies for the treatment of patients with advanced neuroendocrine tumors
Jennifer Chan (2007)
10.1259/bjr.74.887.741065
Imaging appearances of metastases from neuroendocrine tumours of the pancreas.
M P Debray (2001)
10.1159/000098007
Well-Differentiated Gastric Tumors/Carcinomas
P. Ruszniewski (2006)
10.1210/er.2003-0014
The diagnosis and medical management of advanced neuroendocrine tumors.
G. Kaltsas (2004)
10.3747/CO.V15I5.289
Validation of symptom clusters in patients with metastatic bone pain
Stephanie C. Hadi (2008)
10.1159/000051856
Natural History of Neuroendocrine Enteropancreatic Tumors
M. Mignon (2000)
10.1159/000085237
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
U. Plöckinger (2004)
10.1148/rg.261055057
Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings.
Semin Chong (2006)
10.1159/000111037
Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary
Thomas Steinmüller (2007)
10.1378/chest.123.1_suppl.129S
Diagnosis of lung cancer: the guidelines.
M Patricia Rivera (2003)
Frascati Consensus Conference , European Neuroendocrine Tumor Society : Well differentiated gastric tumors / carcinomas
P Ruszniewski (2006)
Endocrine Gastroenteropancreatic Tumors
Dik J. Kwekkeboom (2005)
10.1038/ncponc1323
Effect of bisphosphonates on pain and quality of life in patients with bone metastases
Luís Costa (2009)
10.1159/000109876
Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma
U Plöckinger (2007)
10.1159/000111034
Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma
B. Eriksson (2007)
10.1210/jc.2008-1349
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.
Françoise Montravers (2009)
10.2967/jnumed.106.035667
68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
M. Gabriel (2007)
10.1159/000080731
Epidemiology of Neuroendocrine Tumours
Babs G. Taal (2004)
10.1634/theoncologist.10-2-123
Metastatic carcinoid tumors: a clinical review.
Johanna Maria Zuetenhorst (2005)
[Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)].
B. Kos-Kudła (2008)
10.1023/A:1008215730767
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.
Eva Tiensuu Janson (1997)
10.1378/chest.114.2.526
Pulmonary metastases of endocrine origin: the role of surgery.
Jamal H Khan (1998)
10.1159/000109976
Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin
Håkan Ahlman (2007)
10.1159/000098008
Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas)
R. Jensen (2006)
Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism.
Wim G. Meijer (2003)
10.1002/cncr.11105
A 5-decade analysis of 13,715 carcinoid tumors.
Irvin Mark Modlin (2003)
10.1007/s00330-004-2590-z
Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours
H. Amthauer (2004)
10.1159/000098010
Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
W. D. de Herder (2006)
10.1378/chest.119.1.14
The surgical spectrum of pulmonary neuroendocrine neoplasms.
William A. Cooper (2001)
10.1159/000080742
Somatostatin and Other Peptide Receptors as Tools for Tumor Diagnosis and Treatment
Jean Claude Reubi (2004)
10.1002/cncr.23883
Neuroendocrine tumor epidemiology: contrasting Norway and North America.
Oyvind Hauso (2008)
10.1677/ERC-07-0288
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
S. Grozinsky-Glasberg (2008)
10.1159/000151562
Thirteen-Month Registration of Patients with Gastroenteropancreatic Endocrine Tumours in France
Catherine Lombard-Bohas (2008)
10.1159/000098013
Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)
Ola Nilsson (2006)
10.1016/j.beem.2004.11.016
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
Kjell E Oberg (2005)
10.1159/000098011
Rare Functioning Pancreatic Endocrine Tumors
Dermot O'toole (2006)
10.1159/000111036
Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Colon and Rectum Tumour/Carcinoma
John K. Ramage (2007)
10.1097/SPC.0b013e3282efd70b
Role of radiation therapy and radiopharmaceuticals in bone metastases
Alysa M. Fairchild (2007)
Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
Rachida Lebtahi (1999)
10.1200/JCO.2005.08.066
Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.
D. Kwekkeboom (2005)
10.1159/000151222
Parathyroid Hormone-Related Peptide-Secreting Pancreatic Neuroendocrine Tumours: Case Series and Literature Review
R. Srirajaskanthan (2008)
10.1002/cncr.23469
Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
Irfan Kayani (2008)
10.1159/000098012
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
Massimo Falconi (2006)
10.1148/rg.272065058
Anatomic and functional imaging of metastatic carcinoid tumors.
A. Scarsbrook (2007)
10.1002/cncr.20659
Carcinoid metastasis to the brain.
R. Hlatký (2004)
10.1002/cncr.23542
Bronchopulmonary neuroendocrine tumors.
B. Gustafsson (2008)



This paper is referenced by
10.1016/j.concog.2019.102796
Attentional blink affected by acute stress in women: The role of affective stimuli and attentional resources
Yuecui Kan (2019)
Évaluation de l’apport diagnostique de la TEP-TDM au 68Ga-DOTA-TOC comparée à la scintigraphie monophotonique des récepteurs de la somatostatine dans la néoplasie endocrinienne multiple de type 1
Paul Schwartz (2015)
10.1159/000322123
Neuroendokrine Tumoren – medikamentöse Therapie
Marianne Pavel (2010)
10.3978/j.issn.2305-5839.2013.03.01
Therapy for metastatic pancreatic neuroendocrine tumors.
Roberta Elisa Rossi (2014)
10.12998/wjcc.v7.i13.1554
Role of the brain-gut axis in gastrointestinal cancer
Yang-Zi Di (2019)
10.1055/a-0604-2924
[Practice guideline neuroendocrine tumors - AWMF-Reg. 021-27].
Anja Rinke (2018)
10.1097/MD.0000000000020564
Resection for pancreatic cancer metastases contributes to survival
Hiroki Sato (2020)
Small Intestinal A Rare Malignancy with Favorable Outcome
Olov Norlén (2012)
10.1007/s00104-011-2073-0
Metastasierte neuroendokrine Neoplasien
Marianne Pavel (2011)
10.1159/000504256
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine Neoplasms
Kok Haw Jonathan Lim (2019)
10.1016/J.REVMED.2016.01.012
Tumeurs neuroendocrines digestives
Louis de Mestier (2016)
10.1016/j.hpb.2018.09.020
Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association.
J. Mansour (2019)
10.1093/annonc/mdv041
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
M. Caplin (2015)
10.1093/jas/skz373
Dietary pterostilbene supplementation attenuates intestinal damage and immunological stress of broiler chickens challenged with lipopolysaccharide1.
Hao Zhang (2019)
10.1016/j.jtho.2019.02.002
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors.
Patrick Robelin (2019)
10.3413/Nukmed-0614-13-08
Can peptide receptor radionuclide therapy be safely applied in florid bone metastases? A pilot analysis of late stage osseous involvement.
A. Sabet (2014)
10.1007/s12020-019-01838-8
The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice
Krystallenia I. Alexandraki (2019)
10.4103/1450-1147.172307
Metabolic Bone Disease in the Context of Metastatic Neuroendocrine Tumor: Differentiation from Skeletal Metastasis, the Molecular PET–CT Imaging Features, and Exploring the Possible Etiopathologies Including Parathyroid Adenoma (MEN1) and Paraneoplastic Humoral Hypercalcemia of Malignancy Due to PTH
Rohit R Ranade (2017)
10.1159/000335597
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Marianne E. Pavel (2011)
10.1102/1470-7330.2013.0007
Staging of neuroendocrine tumours: comparison of [68Ga]DOTATOC multiphase PET/CT and whole-body MRI
Christina Schraml (2013)
10.18632/oncotarget.14156
Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases
Jingfei Guo (2017)
10.1002/9781119013143.ch52
50. Neuroendocrine tumours
Dermot O’Toole (2015)
10.1002/9781118512074.ch57
57. Zollinger–Ellison Syndrome
Robert T. Jensen (2015)
10.2217/fon-2016-0092
Management of bronchial carcinoids: international practice survey among the European Society of Thoracic Surgeons.
P. Filosso (2016)
10.1007/s00104-011-2072-1
Neuroendokrine kolorektale Tumoren
Hubert Georg Hotz (2011)
10.1007/978-3-319-50296-0_7
Neuroendocrine Pancreatic Tumors
Marco Miotto (2018)
10.1007/978-3-319-92860-9_36
Resection Versus Chemotherapy for Metastatic Neuroendocrine Tumors of the Pancreas
Kathleen K Christians (2018)
10.1007/s11154-018-9442-7
Neuroendocrine neoplasms – still a challenge despite major advances in clinical care with the development of specialized guidelines
Stephan Petersenn (2018)
10.1007/s11154-017-9429-9
Management of pulmonary neuroendocrine tumors
Robert A. Ramirez (2017)
10.1007/978-3-319-59024-0_23
Therapy for Metastatic Disease: Bronchi
Kjell Öberg (2018)
10.1159/000438902
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition
M. Cives (2015)
Clinical and immunohistochemical studies of small bowel carcinoid tumours
Kalle Landerholm (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar